Trials / Active Not Recruiting
Active Not RecruitingNCT01357668
An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 800 (estimated)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 17 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the long-term safety of Abatacept for the treatment of juvenile idiopathic arthritis (JIA) with particular in interest in the occurrence of serious infections, autoimmune disorders, and malignancies.
Conditions
Timeline
- Start date
- 2013-01-30
- Primary completion
- 2029-01-02
- Completion
- 2029-01-02
- First posted
- 2011-05-23
- Last updated
- 2025-09-25
Locations
59 sites across 25 countries: United States, Austria, Brazil, Canada, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Latvia, Mexico, Netherlands, Norway, Peru, Portugal, Puerto Rico, Romania, Russia, Saudi Arabia, Slovakia, South Africa, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT01357668. Inclusion in this directory is not an endorsement.